Healio: Combining exenatide with pioglitazone improves HbA1c levels in type 2 diabetes

A new study has found that combining the drug pioglitazone with exenatide, in the form of AstraZeneca’s bydureon therapy, provides better blood sugar control in type 2 diabetes than insulin alone and helps promote weight loss.

Read the full story at Healio



Share This Article!
Article Categories: In the News